Advertisement
Screener

EXOZYMES INC. (EXOZ) Cash and Restricted Cash

2.8 / 5 stars · 68/120 Roast Me

EXOZYMES INC. Cash and Restricted Cash

EXOZYMES INC. (EXOZ) had Cash and Restricted Cash of $5.65 million as of 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13

  • 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.65M.
  • 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.44M.
  • 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.04M.
  • 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.10M.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
2026-06-30$5.65M
10-Q · filed 2026-08-13
2026-03-31$1.44M
10-Q · filed 2026-05-14
2025-12-31$3.04M
10-Q · filed 2026-08-13
2025-09-30$5.10M
10-Q · filed 2025-11-13
2025-06-30$6.99M
10-Q · filed 2026-08-13
2025-03-31$8.51M
10-Q · filed 2026-05-14
2024-12-31$9.72M
10-Q · filed 2026-08-13
2024-09-30$233.94K
10-Q · filed 2025-11-13
2024-06-30$158.24K
10-Q · filed 2025-08-12
2024-03-31$113.80K
10-Q · filed 2025-05-12
2023-12-31$66.53K
10-K · filed 2026-03-30
2023-09-30$474.56K
10-Q · filed 2024-11-12
2022-12-31$558.57K
10-K · filed 2025-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73
BioStem Technologies, Inc. (BSEM)United States$0.069B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02